Moran ben David
Direktor/Vorstandsmitglied bei Immunyx Pharma Ltd.
Aktive Positionen von Moran ben David
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Immunyx Pharma Ltd.
 Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 01.04.2021 | - |
Van Leer Xenia Ventures
 Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel. | Corporate Officer/Principal | 01.07.2019 | - |
Karriereverlauf von Moran ben David
Ehemalige bekannte Positionen von Moran ben David
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GSK PLC | Direktor/Vorstandsmitglied | 01.04.2015 | 02.05.2017 |
| NOVARTIS AG | Direktor/Vorstandsmitglied | 01.01.2014 | 02.08.2016 |
Ausbildung von Moran ben David
| Questrom School of Business | Masters Business Admin |
| Tel-Aviv University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Israel | 3 |
| Vereinigtes Königreich | 2 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GSK PLC | Health Technology |
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Immunyx Pharma Ltd.
Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Health Technology |
Van Leer Xenia Ventures
Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel. | Finance |
- Börse
- Insiders
- Moran ben David
- Erfahrung
